Market Size -Epileptic seizure treatment refers to the medical interventions and therapies aimed at managing and controlling seizures in individuals with epilepsy, a neurological disorder characterized by recurrent and unpredictable seizures. Treatment options for epileptic seizures may include medications, lifestyle modifications, dietary therapies, and other interventions tailored to the specific needs of each patient to reduce the frequency and severity of seizures and improve overall quality of life.Sizing and ForecastThe epileptic seizures treatment market size has grown strongly in recent years. It will grow from $3.21 billion in 2023 to $3.42 billion in 2024 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to advancements in antiepileptic drugs (AEDs), research breakthroughs in epilepsy treatment, increased awareness and education, expanded access to healthcare, and a rise in the prevalence of epilepsy.The epileptic seizures treatment market size is expected to see strong growth in the next few years. It will grow to $4.43 billion in 2028 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to precision medicine approaches, emerging therapeutic modalities, telemedicine and remote monitoring, healthcare integration and multidisciplinary care, and regulatory support and incentives. Major trends in the forecast period include personalized medicine, integration of digital health solutions, emerging therapeutic modalities, focus on comorbidities and quality of life, and regulatory support and market access.Order your report now for swift delivery, visit the link:https://www.thebusinessresearchcompany.com/report/epileptic-seizures-treatment-global-market-reportSegmentation & Regional InsightsThe epileptic seizures treatment market covered in this report is segmented -1) By Type: Treatment Practices, Emerging Drugs, Individual Therapies2) By Seizure Type: Partial Seizures, Generalized Seizures, Unclassified Seizures3) By Route of Administration: Oral Or Buccal, Nasal, Rectal, Parenteral4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online PharmaciesNorth America was the largest region in the epileptic seizures treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the epileptic seizures treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:https://www.thebusinessresearchcompany.com/sample_request?id=15803&type=smpMajor Driver Impacting Market GrowthThe rising prevalence of epilepsy is expected to propel the growth of the epileptic seizures treatment market going forward. Epilepsy is a neurological disorder characterized by recurrent, unprovoked seizures. These seizures are the result of abnormal electrical activity in the brain, which can cause a variety of symptoms, including convulsions, loss of consciousness, and disturbances in sensory perception or behavior. The rising prevalence of epilepsy can be attributed to various factors, such as the higher survival rates of individuals with brain injuries or strokes and a growing aging population. Effective epileptic seizure treatments, primarily through the use of AEDs, can significantly reduce the frequency and severity of seizures in patients. These medications help maintain seizure-free periods by stabilizing neuronal activity in the brain, which is critical for patients'â„¢ daily functioning and overall well-being. For instance, in February 2024, according to the World Health Organization, a Switzerland-based public health agency of the United Nations, approximately 50 million people in the world were suffering from epilepsy, making it one of the most prevalent neurological conditions worldwide. Every year, about 5 million people are diagnosed with epilepsy. Therefore, the rising prevalence of epilepsy is driving the growth of the epileptic seizures treatment market.Key Industry Players
Major companies operating in the epileptic seizures treatment market are Pfizer Inc., Johnson & Johnson Service Inc., Sanofi S.A., Abbott Laboratories, Novartis AG, GlaxoSmithKline plc., Takeda Pharmaceutical Co. Ltd., Medtronic plc, GE HealthCare Technologies Inc., Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., UCB S.A., Eisai Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd., Dragerwerk AG & Co.KGaA, H. Lundbeck A/S, Apotex Inc., Masimo Corporation, Fisher & Paykel Healthcare Limited, Inspiration Healthcare Group Plc., Phoenix Medical Systems (P) Ltd., Marinus Pharmaceuticals Inc., Alexza Pharmaceuticals Inc., Neurelis Inc., Veriton Pharma
The epileptic seizures treatment market report table of contents includes:1. Executive Summary2. Epileptic Seizures Treatment Market Characteristics3. Epileptic Seizures Treatment Market Trends And Strategies4. Epileptic Seizures Treatment Market - Macro Economic Scenario5. Global Epileptic Seizures Treatment Market Size and Growth...31. Epileptic Seizures Treatment Market Other Major And Innovative Companies32. Global Epileptic Seizures Treatment Market Competitive Benchmarking33. Global Epileptic Seizures Treatment Market Competitive Dashboard34. Key Mergers And Acquisitions In The Epileptic Seizures Treatment Market35. Epileptic Seizures Treatment Market Future Outlook and Potential Analysis36.AppendixExplore the trending research reports from TBRC:Contact Us:The Business Research CompanyEurope: +44 207 1930 708Asia: +91 88972 63534Americas: +1 315 623 0293Email: info@tbrc.infoFollow Us On:LinkedIn: https://in.linkedin.com/company/the-business-research-companyTwitter: https://twitter.com/tbrc_infoFacebook: https://www.facebook.com/TheBusinessResearchCompanyYouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQBlog: https://blog.tbrc.info/Healthcare Blog: https://healthcareresearchreports.com/Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Epileptic Seizures Treatment Market: IntroductionAccording to the report, the global epileptic seizures treatment market was valued at US$ 1.2 Bn in 2019 and is projected to expand at a CAGR of ~4% from 2020 to 2030.
Treatment for epileptic seizures include benzodiazepines, phenytoin, and dosphenytoin.
According to the World Health Organization (WHO), epilepsy accounts for a considerable proportion of the world’s disease burden; globally, more than 50 million people are affected by this disease.
The retail pharmacies segment accounted for major share of the global market in 2019 due to easy availability of branded as well as generic drugs, increase in number of pharmacy retail chain stores, and joint ventures & strategic collaboration partnerships between retail pharmacy giants.Buy Epileptic Seizures Treatment Market Report –https://www.transparencymarketresearch.com/checkout.php?rep_id=79717=SNorth America to Dominate Global MarketThe global epileptic seizures treatment market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
North America accounted for a major share of the global epileptic seizures treatment market in 2019, owing to rise in prevalence of neurological disorders, increase in brain injuries, recent drug approvals, and well-established healthcare infrastructure.
An article published by the National Center for Biotechnology Information, U.S. Library of Medicine in February 2016 stated that every year 50,000 to 150,000 people in the U.S. suffer from status epilepticus, with mortality estimated at less than 3% in children, but up to 30% in adults.
